Department of Orthopedic Surgery, NYU Langone Health, NYU Langone Orthopedic Hospital, New York, NY, USA.
Department of Orthopedic Surgery, Health and Hospitals, Bellevue, New York, NY, USA.
Eur J Orthop Surg Traumatol. 2021 Oct;31(7):1451-1456. doi: 10.1007/s00590-021-02902-8. Epub 2021 Feb 22.
The purpose of this study is to describe a Level 1 Trauma Center's orthopedic response to the COVID-19 pandemic, and to compare outcomes of acute fracture patients pre-COVID versus during the COVID-19 pandemic.
All inpatient fracture cases performed over a 5-month period were identified and retrospective chart review performed. Patients were divided into pre- and COVID-era groups based on when surgery was performed relative to March 16, 2020 (the date elective operations were ceased), and groups were statistically compared. Patients with a COVID test result were further sub-divided into COVID negative and positive groups, and statistically compared. Statistical analysis was performed using independent t-test for continuous variables and chi-square analysis for categorical variables.
One hundred and nineteen patients were identified, 38% females with average age of 58 years. Average length of stay was 7 days with average time from injury to surgery of 3 days and average time from admission to surgery of 1.3 days. Overall in-hospital complication rate was 29.4%, and 30-day mortality and readmission rates were 2.5% and 5%, respectively. Sixty-nine patients comprised the pre-COVID group, and 50 in the COVID-era group. There was no significant difference with respect to length of stay, time from injury to surgery, time from admission to surgery, need for post-operative ICU stay, in-hospital complication rate, 30-day mortality rate and 30-day readmission rate. Thirty-four patients had COVID testing, with 24 negative and 10 positive. COVID-positive patients had longer time from injury to surgery (8.5 days vs. 2 days, p = 0.003) and longer time from admission to surgery (2.7 days vs. 1.2 days, p = 0.034). While more COVID-positive patients required ICU admission post-operatively (60% vs. 21%, p = 0.036), there was no difference in overall complication rate.
Orthopedic care of acute fracture patients was not affected by a global pandemic. The response of our Level 1 Trauma Center's orthopedic department can guide other hospitals if and when new surges in COVID cases arise, in order to prevent compromising appropriate orthopedic care.
Prognostic III.
本研究旨在描述一家一级创伤中心应对 COVID-19 大流行的骨科反应,并比较 COVID-19 大流行前后急性骨折患者的结局。
确定并回顾了在 5 个月期间接受的所有住院骨折病例。根据手术相对于 2020 年 3 月 16 日(停止择期手术的日期)的时间,将患者分为 COVID 前和 COVID 时代组,并进行统计学比较。进一步将有 COVID 检测结果的患者分为 COVID 阴性和阳性组,并进行统计学比较。使用独立 t 检验进行连续变量的统计分析,使用卡方分析进行分类变量的统计分析。
共确定了 119 名患者,其中 38%为女性,平均年龄为 58 岁。平均住院时间为 7 天,从受伤到手术的平均时间为 3 天,从入院到手术的平均时间为 1.3 天。总体院内并发症发生率为 29.4%,30 天死亡率和再入院率分别为 2.5%和 5%。69 名患者为 COVID 前组,50 名患者为 COVID 时代组。在住院时间、从受伤到手术的时间、从入院到手术的时间、术后 ICU 入住需求、院内并发症发生率、30 天死亡率和 30 天再入院率方面均无显著差异。34 名患者进行了 COVID 检测,其中 24 名检测结果为阴性,10 名检测结果为阳性。COVID 阳性患者从受伤到手术的时间更长(8.5 天 vs. 2 天,p=0.003),从入院到手术的时间也更长(2.7 天 vs. 1.2 天,p=0.034)。虽然更多的 COVID 阳性患者需要术后 ICU 入住(60% vs. 21%,p=0.036),但总体并发症发生率无差异。
全球大流行并未影响急性骨折患者的骨科治疗。我们的一级创伤中心骨科部门的应对措施可以为其他医院提供指导,如果 COVID 病例再次激增,以便在不影响适当骨科治疗的情况下预防。
预后 III 级。